Even as the medical industry remains under fire for overprescribing medication amidst the nation’s ongoing opioid crisis, nothing changes the fact that people suffering from chronic pain rely on pain relief solutions to get through the day.
Pain relief technology startup Oska Wellness announced this week that the company raised $5.5 million in seed funding on its quest to provide drug-free alternatives for pain management to the 100 million Americans who suffer daily from chronic pain.
The company’s Oska Pulse device employs pulsed electromagnetic field therapy, a non-invasive way to aid circulation, boost cell repair and increase mobility for those with acute or chronic pain. Oska says that the investors participating in this latest round are not only healthcare industry veterans, but users of Oska Pulse.
“We’re thrilled to close this first round of funding. Over 100 million Americans suffer daily from chronic pain and everyone involved in the round knows personally and professionally how debilitating it can be.”
“We’re thrilled to close this first round of funding. Over 100 million Americans suffer daily from chronic pain and everyone involved in the round knows personally and professionally how debilitating it can be,” said Greg Houlgate, co-founder of Oska Wellness, in a statement.
“This equity will further expand our efforts to help people live more active lives with less pain. We want to make a drug-free alternative available, accessible and affordable to everyone struggling with pain as they seek to reclaim their lives—and our wearable, tech-driven Oska Pulse device is that alternative,” he continued.
Plans for the new capital include sales, marketing, distribution and product development.
